Filtered By:
Drug: Methylphenidate

This page shows you your search results in order of date.

Order by Relevance | Date

Total 148 results found since Jan 2013.

There Is No Evidence That Links ADHD Meds To Substance Use Disorder
A new study says taking ADHD medicines like methylphenidate during childhood are not associated with substance use disorders in early adulthood.
Source: Forbes.com Healthcare News - July 5, 2023 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news

What Are the Symptoms of Serotonin Syndrome?
Discussion Serotonin syndrome (SS) is a clinical diagnosis and problem which can be seen in patients of all ages. Classically SS presents with changing mental status, autonomic dysfunction and neuromuscular excitability. It is caused by increased serotonin levels because of therapeutically increasing the dose of a medication already being taken, adding an additional serotoninergic medication or one that potentiates serotonin, overlapping transition when changing medications, or intentional or unintentional overdose. It has become more common especially as selective serotonin reuptake inhibitors (SSRIs) have been used more ...
Source: PediatricEducation.org - May 8, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Featured Review: Methylphenidate for children and adolescents with ADHD
Monday, March 27, 2023
Source: Cochrane News and Events - March 27, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea - Park J, Lee DY, Kim C, Lee YH, Yang SJ, Lee S, Kim SJ, Lee J, Park RW, Shin Y.
BACKGROUND: Methylphenidate (MPH) is the most frequently prescribed medication for the treatment of attention deficit hyperactivity disorder (ADHD). However, the safety of its long-term use remain unclear. In particular, real-world evidence of long-term MP...
Source: SafetyLit - October 13, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Methylphenidate Is Overprescribed to Children in France Methylphenidate Is Overprescribed to Children in France
New prescriptions for methylphenidate have been increasing in France, data show. These prescriptions sometimes are written in the absence of a diagnosis of ADHD, which is the drug ' s only indication.Medscape Medical News
Source: Medscape Internal Medicine Headlines - April 14, 2022 Category: Internal Medicine Tags: Psychiatry News Source Type: news

The effects of methylphenidate treatment on bullying perpetration and victimization in children and adolescents with attention-deficit/hyperactivity disorder - Karaosman T, Gumus YY.
OBJECTIVE: Although it is known that attention-deficit/hyperactivity disorder (ADHD) increases the risk of bullying perpetration and victimization, the data on the effect of methylphenidate (MPH) treatment, which is frequently used in the treatment of ADHD...
Source: SafetyLit - March 7, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

ADHD Med May Reduce Apathy in Alzheimer ' s Disease ADHD Med May Reduce Apathy in Alzheimer ' s Disease
Methylphenidate is associated with a significantly greater reduction in apathy in patients with Alzheimer ' s disease compared with placebo -- and has a good safety profile, a new phase 3 trial suggests.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - October 4, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Treatment with methylphenidate for attention deficit hyperactivity disorder (ADHD) and the risk of all-cause poisoning in children and adolescents: a self-controlled case series study - Gao L, Man KKC, Chan EW, Chui CSL, Li X, Coghill D, Hon KL, Tse ML, Lum TYS, Wong KHTW, Ip P, Wong ICK.
BACKGROUND: Children and adolescents with attention deficit hyperactivity disorder (ADHD) are at higher risk of all-cause poisoning by drugs and chemicals (intentional or accidental). Currently, there is limited data on whether medication treatment for ADH...
Source: SafetyLit - July 25, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Micro-PET/CT shows long-term Ritalin use safe in ADHD
Adults who started taking methylphenidate, also known as Ritalin, when the...Read more on AuntMinnie.comRelated Reading: Functional, diffusion MRI could benefit from AI AI-based model aids fMRI in ADHD detection MRI shows effect of Ritalin on kids' brains SPECT shows causes of accelerated brain aging fMRI shows how game therapy 'rewires' ADHD brains
Source: AuntMinnie.com Headlines - July 15, 2021 Category: Radiology Source Type: news

New Obesity Target? Dopamine Circuit in Brainstem Affects Satiety New Obesity Target? Dopamine Circuit in Brainstem Affects Satiety
A newly identified dopaminergic neural circuit in the hindbrain plays a role in satiety, a mouse study found, which methylphenidate, approved for ADHD, but which also causes appetite loss, acts on.Medscape Medical News
Source: Medscape Medical News Headlines - June 4, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Drug Holiday? Benefits, Risk to Kids With ADHD Drug Holiday? Benefits, Risk to Kids With ADHD
Letting children with ADHD take a weekend or summer break from methylphenidate may lead to several benefits, but experts urge caution when doing so.Medscape Medical News
Source: Medscape Medical News Headlines - May 13, 2021 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Students' stimulant use for cognitive enhancement: a deliberate choice rather than an emotional response to a given situation - Ponnet K, Tholen R, De Bruyn S, Wouters E, Van Ouytsel J, Walrave M, Van Hal G.
BACKGROUND: Prescription stimulants such as methylphenidate are usually prescribed to treat attention deficit (and hyperactivity) disorders (ADHD). Recently, these drugs have gained popularity among college students, because of the belief that they can hel...
Source: SafetyLit - December 3, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Methylphenidate and the risk of burn injury among children with attention-deficit/hyperactivity disorder - Chen VCH, Yang YH, Yu Kuo T, Lu ML, Tseng WT, Hou TY, Yeh JY, Lee CTC, Chen YL, Lee MJ, Dewey ME, Gossop M.
AIMS: Attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk of burn injury than in the normal population. Nevertheless, the influence of methylphenidate (MPH) on the risk of burn injury remains unclear. This retrospective cohort ...
Source: SafetyLit - July 23, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: population-based cohort study - Chen VCH, Chan HL, Wu SI, Lu ML, Dewey ME, Stewart R, Lee CTC.
BACKGROUND: Little is known about methylphenidate (MPH) use and mortality outcomes. AIMS: To investigate the association between MPH use and mortality among children with an attention-deficit hyperactivity disorder (ADHD) diagnosis. METHOD: This po...
Source: SafetyLit - July 17, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Association of methylphenidate use and traditional/cyberbullying - Tural Hesapcioglu S, Kandemir G.
This study aims to determine whether there is a difference in terms of traditional/cyberbullying or victimization among adolescents receiving methylphenidate for attention deficit hyperactivity disorder (ADHD) and treatment-na ïve adolescents w...
Source: SafetyLit - February 8, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news